| 000 | 01311 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513210140.0 | ||
| 264 | 0 | _c20000620 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0012-6667 | ||
| 024 | 7 |
_a10.2165/00003495-200059030-00015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFiggitt, D P | |
| 245 | 0 | 0 |
_aDocetaxel: an update of its use in advanced breast cancer. _h[electronic resource] |
| 260 |
_bDrugs _cMar 2000 |
||
| 300 |
_a621-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEconomics, Pharmaceutical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aPaclitaxel _xanalogs & derivatives |
| 650 | 0 | 4 | _aTaxoids |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 700 | 1 | _aWiseman, L R | |
| 773 | 0 |
_tDrugs _gvol. 59 _gno. 3 _gp. 621-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003495-200059030-00015 _zAvailable from publisher's website |
| 999 |
_c10729811 _d10729811 |
||